Tocqueville Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Sell	87,000 -20,000	-19%	-$63.3K	﹤0.01%	511
2025 Q4	$396K	Buy	107,000 +16,000	+18%	+$51.7K	0.01%	480
2025 Q3	$241K	Buy	91,000 +27,500	+43%	+$53.2K	﹤0.01%	520
2025 Q2	$62.5K	Sell	63,500 -1,500	-2%	-$1.5K	﹤0.01%	531
2025 Q1	$93.6K	Sell	65,000 -5,000	-7%	-$9.21K	﹤0.01%	507
2024 Q4	$154K	Sell	70,000 -2,500	-3%	-$5.83K	﹤0.01%	530
2024 Q3	$120K	Sell	72,500 -5,000	-6%	-$10.1K	﹤0.01%	518
2024 Q2	$172K	Buy	77,500 +37,750	+95%	+$88.8K	﹤0.01%	508
2024 Q1	$107K	Buy	+39,750	New	+$96.6K	﹤0.01%	524
2020 Q3	–	Sell	-5,500	Closed	-$282K	–	660
2020 Q2	$282K	Buy	+5,500	New	+$230K	0.01%	574
2020 Q1	–	Sell	-5,500	Closed	-$328K	–	656
2019 Q4	$328K	Buy	+5,500	New	+$247K	﹤0.01%	634
2018 Q2	–	Sell	-2,975	Closed	-$215K	–	832
2018 Q1	$215K	Buy	+2,975	New	+$218K	﹤0.01%	772